155 related articles for article (PubMed ID: 17202302)
1. Expression profiling and lung cancer development.
Borczuk AC; Powell CA
Proc Am Thorac Soc; 2007 Jan; 4(1):127-32. PubMed ID: 17202302
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of non-small-cell lung cancer.
Lacroix L; Commo F; Soria JC
Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
Dacic S
Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer in never smokers: a review.
Subramanian J; Govindan R
J Clin Oncol; 2007 Feb; 25(5):561-70. PubMed ID: 17290066
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers.
Schuller HM; Porter B; Riechert A; Walker K; Schmoyer R
Lung Cancer; 2004 Jul; 45(1):11-8. PubMed ID: 15196729
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tumors of the lung. Pathology and molecular biology.
Vuitch F; Sekido Y; Fong K; Mackay B; Minna JD; Gazdar AF
Chest Surg Clin N Am; 1997 Feb; 7(1):21-47. PubMed ID: 9001754
[TBL] [Abstract][Full Text] [Related]
8. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
[TBL] [Abstract][Full Text] [Related]
9. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
10. Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice.
Linnoila RI; Zhao B; DeMayo JL; Nelkin BD; Baylin SB; DeMayo FJ; Ball DW
Cancer Res; 2000 Aug; 60(15):4005-9. PubMed ID: 10945598
[TBL] [Abstract][Full Text] [Related]
11. Molecular biologic features of non-small cell lung cancer. Clinical implications.
Rusch VW; Dmitrovsky E
Chest Surg Clin N Am; 1995 Feb; 5(1):39-55. PubMed ID: 7743147
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
[TBL] [Abstract][Full Text] [Related]
13. Common and contrasting genomic profiles among the major human lung cancer subtypes.
Tonon G; Brennan C; Protopopov A; Maulik G; Feng B; Zhang Y; Khatry DB; You MJ; Aguirre AJ; Martin ES; Yang Z; Ji H; Chin L; Wong KK; Depinho RA
Cold Spring Harb Symp Quant Biol; 2005; 70():11-24. PubMed ID: 16869734
[TBL] [Abstract][Full Text] [Related]
14. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer.
Spira A; Beane JE; Shah V; Steiling K; Liu G; Schembri F; Gilman S; Dumas YM; Calner P; Sebastiani P; Sridhar S; Beamis J; Lamb C; Anderson T; Gerry N; Keane J; Lenburg ME; Brody JS
Nat Med; 2007 Mar; 13(3):361-6. PubMed ID: 17334370
[TBL] [Abstract][Full Text] [Related]
15. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
[TBL] [Abstract][Full Text] [Related]
16. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
17. Molecular biologic staging of lung cancer.
D'Amico TA
Ann Thorac Surg; 2008 Feb; 85(2):S737-42. PubMed ID: 18222207
[TBL] [Abstract][Full Text] [Related]
18. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer: future directions.
Lam WK; Watkins DN
Respirology; 2007 Jul; 12(4):471-7. PubMed ID: 17587411
[TBL] [Abstract][Full Text] [Related]
20. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
